China Construction Bank (CCB) is building a 2.6 billion RMB ($380 million) private equity fund which will invest in expanding-to-mature China healthcare companies that have not made their IPOs. The goal of the fund is to invest in companies at a price-earnings ratio of ten. RMB-denominated funds are becoming an increasingly important factor in China’s investment world as the international investment environment changes. More details...

Stock Symbol: (HK: 0939)